AJMC May 25, 2023
By Julia Bonavitacola

Although lack of routine testing and limitations to current diagnostic testing likely lead to underreporting of respiratory syncytial virus, RSV still poses a substantial economic burden.

Respiratory syncytial virus (RSV) was found to be an economic burden despite probable underreporting due to lack of routine testing, according to a study published in Journal of Medical Economics.

RSV is a seasonal virus that affects children and older adults. Approximately 470,000 adults 60 years and older have experienced an RSV-associated hospitalization and 33,000 in-hospital deaths areassociated with RSV. The management of acute respiratory infections has been previously estimated but did not report respiratory pathogen-specific management costs, the authors of the present study noted. This systematic literature review aimed to summarize...

Today's Sponsors

Upfront Healthcare

Today's Sponsor


Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
COVID Boosters See More Vaccine Hesitancy Than Flu & RSV Shots
WHO recommends dropping component of many flu vaccines
Insurers argue that they're not to blame for snags in COVID-19 vaccine rollout
Older adults’ vaccine plans concern infectious disease experts
As COVID infections rise, nursing homes still waiting for vaccines

Share This Article